Page 19 - Serum Institute Of India

India gets Covid-19 vaccine: DCGI nod for Serum Institute, Bharat Biotech

Health Minister Harsh Vardhan termed it a 'watershed moment in India's battle against Covid-19'

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

Next step on vaccines

Nationwide roll-out needs meticulous planning

All risks paid off, India proud: SII, Bharat Biotech on Covid vaccine nod

With the government approving two Covid-19 vaccines for emergency use, Serum Institute said it is ready to roll out Covishield vaccine in India in the coming weeks

Congress not proud of anything Indian: Nadda over vaccine approval concerns

"Congress and the Opposition is not proud of anything Indian. They should introspect about how their lies on the Covid-19 vaccine will be used by vested interest groups for their own agendas," he said

SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report

He said that the vaccine will be rolled out in the next 7 to 10 days

Approval for vaccines accelerates India's journey to be Covid-free: Modi

Modi said it will make every Indian proud that both the vaccines are made in India

India approves two coronavirus vaccines for restrictive, emergency use

Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

Covishield moves closer to roll-out; SII gets in-principle nod from panel

India would need 30 million doses in the first phase when it vaccinates the essential services workers including health care professionals, municipal and police staff, etc

The story behind the rise of Serum Institute, world's vaccine factory

Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses

Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

US giant Pfizer did not come to present its case on Friday before the Subject Expert Committee

Panel clears Covid-19 vaccine manufactured by Serum Institute: Reports

The Serum Institute of India (SII), the local maker of the vaccine called Covishield, has stockpiled about 50 million doses of the vaccine, enough for 25 million people, said its CEO last week

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine

India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech

India drug regulator meets to discuss AstraZeneca vaccine: Report

SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people

UK nod to Astra vaccine positive news, waiting for India's approval: SII

SII termed the approval for Oxford-AstraZeneca Covid-19 vaccine in the UK as encouraging news

Serum Institute's vaccine to be considered for emergency approval today

The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca